ANI PHARMACEUTICALS INC Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Ani Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Ani Pharmaceuticals Inc Return On Equity for the quarter ending September 30, 2024 was -1.62 %, a 145% decline year-over-year.
  • Ani Pharmaceuticals Inc annual Return On Equity for 2023 was 4.73 %.
  • Ani Pharmaceuticals Inc annual Return On Equity for 2022 was -15.2 %, a 17.8% increase from 2021.
  • Ani Pharmaceuticals Inc annual Return On Equity for 2021 was -18.5 %, a 60.7% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 4.73 +20 Jan 1, 2023 Dec 31, 2023
2022 -15.2 +3.29 +17.8% Jan 1, 2022 Dec 31, 2022
2021 -18.5 -6.99 -60.7% Jan 1, 2021 Dec 31, 2021
2020 -11.5 -14.4 -494% Jan 1, 2020 Dec 31, 2020
2019 2.93 -5.29 -64.4% Jan 1, 2019 Dec 31, 2019
2018 8.21 +8.82 Jan 1, 2018 Dec 31, 2018
2017 -0.61 -2.98 -125% Jan 1, 2017 Dec 31, 2017
2016 2.38 -7.7 -76.4% Jan 1, 2016 Dec 31, 2016
2015 10.1 -17.1 -62.9% Jan 1, 2015 Dec 31, 2015
2014 27.2 +26.3 +3042% Jan 1, 2014 Dec 31, 2014
2013 0.87 +11.2 Jan 1, 2013 Dec 31, 2013
2012 -10.3 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.